These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 13939594)

  • 1. Coronary sclerosis and anticoagulant.
    OGINO K
    Jpn Circ J; 1963 Feb; 27():181-6. PubMed ID: 13939594
    [No Abstract]   [Full Text] [Related]  

  • 2. ANTICOAGULANT ACTION OF ADENOSINE TRIPHOSPHATE.
    QUICK AJ
    Nature; 1963 Nov; 200():469-70. PubMed ID: 14076730
    [No Abstract]   [Full Text] [Related]  

  • 3. MAO inhibitor and anticoagulant in shortening of prothrombin time by adrenaline, cholesterol and traumatization.
    SHIMAMOTO T; TAKEUCHI K; ISHIOKA T
    Chemotherapia (Basel); 1962; 4():227-36. PubMed ID: 13911936
    [No Abstract]   [Full Text] [Related]  

  • 4. Rosuvastatin Reduces Aortic Sinus and Coronary Artery Atherosclerosis in SR-B1 (Scavenger Receptor Class B Type 1)/ApoE (Apolipoprotein E) Double Knockout Mice Independently of Plasma Cholesterol Lowering.
    Yu P; Xiong T; Tenedero CB; Lebeau P; Ni R; MacDonald ME; Gross PL; Austin RC; Trigatti BL
    Arterioscler Thromb Vasc Biol; 2018 Jan; 38(1):26-39. PubMed ID: 29162602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Anticoagulant therapy. Use in a new prothrombin activity range].
    de ALMEIDA E; GINEFRA P; MONTEIRO MM; RIBEIRO CP; de ALMEIDA A
    Rev Bras Oftalmol; 1960 Dec; 17():1024-33. PubMed ID: 13860659
    [No Abstract]   [Full Text] [Related]  

  • 6. Views on diet, cholesterol inhibition, and long-term anticoagulants in ischaemic heart disease.
    GOODWIN JF; WILCKEN DE; HARRISON R; BLOOM VR
    J Assoc Physicians India; 1963 Jan; 11():9-20. PubMed ID: 13949120
    [No Abstract]   [Full Text] [Related]  

  • 7. The use of anticoagulants in the treatment and prevention of coronary artery disease and myocardial infarction.
    NICHOL ES
    New Orleans Med Surg J; 1949 Dec; 102(6):289-94. PubMed ID: 15399035
    [No Abstract]   [Full Text] [Related]  

  • 8. [Aorto-coronary atherosclerosis. Relation between the anatomical lesions, lipemia, cholesteremia and lipid electrophoresis].
    GARCIA DADONI L; BURRIER C; DE LA RIEGA E; MAZZEI CM
    Prensa Med Argent; 1963 Jan; 50():63-70. PubMed ID: 13960408
    [No Abstract]   [Full Text] [Related]  

  • 9. The LDL-cholesterol to HDL-cholesterol ratio and the severity of coronary and aortic atherosclerosis.
    Momiyama Y; Ohmori R; Fayad ZA; Tanaka N; Kato R; Taniguchi H; Nagata M; Ohsuzu F
    Atherosclerosis; 2012 Jun; 222(2):577-80. PubMed ID: 22516791
    [No Abstract]   [Full Text] [Related]  

  • 10. CORONARY ARTERY DISEASE AND MY DOUBTS.
    CHAND A
    J Indian Med Assoc; 1964 May; 42():490-2. PubMed ID: 14160465
    [No Abstract]   [Full Text] [Related]  

  • 11. ATHEROSCLEROSIS IN THE SQUIRREL MONKEY. NATURALLY OCCURRING LESIONS OF THE AORTA AND CORONARY ARTERIES.
    MIDDLETON CC; CLARKSON TB; LOFLAND HB; PRICHARD RW
    Arch Pathol; 1964 Jul; 78():16-23. PubMed ID: 14148743
    [No Abstract]   [Full Text] [Related]  

  • 12. Inheritability of atherosclerosis and the role of lipoproteins as risk factors in the development of atherosclerosis in WHHL rabbits: risk factors related to coronary atherosclerosis are different from those related to aortic atherosclerosis.
    Shiomi M; Ito T; Shiraishi M; Watanabe Y
    Atherosclerosis; 1992 Sep; 96(1):43-52. PubMed ID: 1418101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [BIOLOGY OF THE PROCESS OF SCLEROSIS. 18. OBSERVATIONS ON ACCUMULATIONS OF ACID MUCOPOLYSACCHARIDES IN THE INTIMA OF THE HUMAN AORTA AND CORONARY ARTERIES].
    VELICAN C
    Stud Cercet Med Interna; 1965; 18():59-62. PubMed ID: 14335611
    [No Abstract]   [Full Text] [Related]  

  • 14. Intracoronary adenosine 5'-triphosphate as an alternative to papaverine for measuring coronary flow reserve.
    Yamada H; Azuma A; Hirasaki S; Kobara M; Akagi A; Shima T; Miyazaki H; Sugihara H; Kohno Y; Asayama J
    Am J Cardiol; 1994 Nov; 74(9):940-1. PubMed ID: 7977126
    [No Abstract]   [Full Text] [Related]  

  • 15. Serum lipoprotein patterns in coronary sclerosis and associated conditions.
    OLIVER MF; BOYD GS
    Br Heart J; 1955 Jul; 17(3):299-302. PubMed ID: 13239924
    [No Abstract]   [Full Text] [Related]  

  • 16. [The effect of the lack of motion on the serum lipids and the formation of aortic- and coronary sclerosis in the cock and fat- and cholesterol-rich food].
    WOLLENBERGER A; KOESSLER A
    Klin Wochenschr; 1960 Jul; 38():665-6. PubMed ID: 13845755
    [No Abstract]   [Full Text] [Related]  

  • 17. [LABORATORY SURVEILLANCE IN ANTICOAGULANT TREATMENT].
    GARAN R
    Actual Cardiol Angeiol Int (Paris); 1964; 13():31-3. PubMed ID: 14185514
    [No Abstract]   [Full Text] [Related]  

  • 18. The management of anticoagulant therapy by a simple blood prothrombin test.
    MANCHESTER B
    Postgrad Med; 1956 Apr; 19(4):311-7. PubMed ID: 13322724
    [No Abstract]   [Full Text] [Related]  

  • 19. Determination of prothrombin concentration as an index of anticoagulant control.
    OWENS JC; ARMBRUST CA; SUTTON WC; LIVESAY WR; WAGNER EL
    Am J Cardiol; 1961 Oct; 8():471-80. PubMed ID: 14482915
    [No Abstract]   [Full Text] [Related]  

  • 20. [Heparin tolerance test and prothrombin time in the control of anticoagulant therapy of coronary infarction].
    HOLLER G; WEINMANN O; HAMMERL H; ZEMANN J
    Wien Klin Wochenschr; 1953 May; 65(20):402-4. PubMed ID: 13078388
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.